Brief: Novozymes Expects Organic Sales Growth Of 5-7% In 2024
21/03/2024 06:30
March 21 (Reuters) - Novozymes A/S NSISb.CO :
* 2024 OUTLOOK AND PRO FORMA FINANCIALS
* PROVIDES OUTLOOK FOR 2024 WITH EXPECTED 5-7% ORGANIC SALES
GROWTH AND AROUND 35% ADJUSTED EBITDA MARGIN
Source text for Eikon: ID:nGNE566ZL7
Further company coverage: NSISb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))